SeaCrest Wealth Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,875
Closed -$24K 717
2022
Q2
$24K Buy
+2,875
New +$40.2K ﹤0.01% 1418
2021
Q2
Sell
-9,036
Closed -$287K 693
2021
Q1
$287K Buy
+9,036
New +$265K 0.04% 493
2020
Q1
Sell
-9,111
Closed -$273K 514
2019
Q4
$273K Sell
9,111
-1,208
-12% -$31.4K 0.05% 424
2019
Q3
$225K Sell
10,319
-1,806
-15% -$41.3K 0.04% 462
2019
Q2
$306K Hold
12,125
0.06% 374
2019
Q1
$299K Sell
12,125
-7,588
-38% -$181K 0.05% 362
2018
Q4
$364K Sell
19,713
-4,516
-19% -$107K 0.08% 276
2018
Q3
$622K Sell
24,229
-9,140
-27% -$209K 0.11% 210
2018
Q2
$775K Sell
33,369
-426
-1% -$8.81K 0.14% 149
2018
Q1
$538K Sell
33,795
-1,078
-3% -$20.1K 0.1% 225
2017
Q4
$725K Buy
+34,873
New +$553K 0.13% 153

Other funds holding BHC

SeaCrest Wealth Management's BHC Position: Q3 2022 in Review

SeaCrest Wealth Management sold out of Bausch Health (BHC) in Q3 2022, closing a stake of 2,875 shares — an estimated $24K sold.

SeaCrest Wealth Management first reported a position in BHC in Q4 2017 and held it in 11 quarters. The position peaked at $775K in Q2 2018. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.

  • SeaCrest Wealth Management reported no remaining Bausch Health position as of Q3 2022 after selling out during the quarter.
  • SeaCrest Wealth Management sold 2,875 Bausch Health shares in Q3 2022, an estimated $24K.
  • SeaCrest Wealth Management first reported a position in Bausch Health in Q4 2017 and held it in 11 quarters.
  • SeaCrest Wealth Management's Bausch Health position peaked at $775K in Q2 2018.
  • 283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.

Based on SeaCrest Wealth Management's 13F filing for Q3 2022, filed 15 Nov 2022.